N/A
N=40
Desflurane Versus Propofol in the Sitting Position
Cerebral Ischemia
Bottom Line
View on ClinicalTrials.gov: NCT01436799 ↗Enrolled (actual)
40
Serious AEs
0.0%
Results posted
Aug 2013
Primary outcome: Primary: Regional Cerebral Oxygen Satuation (rSO2) — 77.4; 72.5; 76; 70 percentage of rSO2 (%)
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- propofol (Drug); Desflurane (Drug); alfentanil (Drug); Rocuronium (Drug)
- Age
- Adult, Older Adult · 20+ yrs
- Sex
- All
- Sponsor
- Gachon University Gil Medical Center
- Primary completion
- Aug 2011
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Regional Cerebral Oxygen Satuation (rSO2) |
77.4; 72.5; 76; 70; 75.2; 70 | — |
Summary
The investigators hypothesized that both propofol and desflurane would decrease the regional oxygen saturation (rSO2) but propofol is likely to reduce rSO2 more than sevoflurane when patients are raised to the sitting position.
Eligibility Criteria
Inclusion Criteria
- Forty patients,
- ASA class I or II,
- undergoing shoulder arthroscopy
Exclusion Criteria
- Patients with history of cerebrovascular disease, coronary occlusive disease and/or obesity (body mass index > 30) were excluded from this study.
Data sourced from ClinicalTrials.gov (NCT01436799). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.